Wird geladen...
Cost burden and net monetary benefit loss of neonatal hypoglycaemia
BACKGROUND: Neonatal hypoglycaemia is a common but treatable metabolic disorder that affects newborn infants and which, if not identified and treated adequately, may result in neurological sequelae that persist for the lifetime of the patient. The long-term financial and quality-of-life burden of ne...
Gespeichert in:
| Veröffentlicht in: | BMC Health Serv Res |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
BioMed Central
2021
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7863541/ https://ncbi.nlm.nih.gov/pubmed/33546675 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12913-021-06098-9 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|